JPWO2022064198A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022064198A5
JPWO2022064198A5 JP2023518817A JP2023518817A JPWO2022064198A5 JP WO2022064198 A5 JPWO2022064198 A5 JP WO2022064198A5 JP 2023518817 A JP2023518817 A JP 2023518817A JP 2023518817 A JP2023518817 A JP 2023518817A JP WO2022064198 A5 JPWO2022064198 A5 JP WO2022064198A5
Authority
JP
Japan
Prior art keywords
subject
gene
foxo1
nafld
arld
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023518817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543763A5 (https=
JP2023543763A (ja
Publication date
Priority claimed from GBGB2015056.1A external-priority patent/GB202015056D0/en
Application filed filed Critical
Publication of JP2023543763A publication Critical patent/JP2023543763A/ja
Publication of JPWO2022064198A5 publication Critical patent/JPWO2022064198A5/ja
Publication of JP2023543763A5 publication Critical patent/JP2023543763A5/ja
Pending legal-status Critical Current

Links

JP2023518817A 2020-09-23 2021-09-23 バイオマーカー Pending JP2023543763A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2015056.1 2020-09-23
GBGB2015056.1A GB202015056D0 (en) 2020-09-23 2020-09-23 Biomarkers
PCT/GB2021/052469 WO2022064198A1 (en) 2020-09-23 2021-09-23 Biomarkers

Publications (3)

Publication Number Publication Date
JP2023543763A JP2023543763A (ja) 2023-10-18
JPWO2022064198A5 true JPWO2022064198A5 (https=) 2024-09-27
JP2023543763A5 JP2023543763A5 (https=) 2024-09-27

Family

ID=73139042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518817A Pending JP2023543763A (ja) 2020-09-23 2021-09-23 バイオマーカー

Country Status (6)

Country Link
US (1) US20230348983A1 (https=)
EP (1) EP4217507A1 (https=)
JP (1) JP2023543763A (https=)
CN (1) CN116867910A (https=)
GB (1) GB202015056D0 (https=)
WO (1) WO2022064198A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250028934A1 (en) * 2023-07-17 2025-01-23 The Toronto-Dominion Bank Systems and methods for time series prediction using multi-stage computation
US20250263702A1 (en) * 2024-02-19 2025-08-21 Flagship Pioneering Innovations Vii, Llc Rnai agents targeting cideb and related methods
WO2025230979A1 (en) * 2024-04-30 2025-11-06 Flagship Pioneering Innovations Vii, Llc Tnfaip3-targeted compositions and related methods
WO2026038054A2 (en) * 2024-08-15 2026-02-19 Genome Research Limited Novel companion diagnostic method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009971A1 (ja) 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
EP2310504A1 (en) * 2008-07-03 2011-04-20 Santaris Pharma A/S Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1)
EP2475781B1 (en) * 2009-09-11 2017-10-25 The Chinese University Of Hong Kong Methods for assessing liver pathologies
JP2018169277A (ja) * 2017-03-29 2018-11-01 国立大学法人神戸大学 炎症性関連病態を伴う非アルコール性脂肪性肝疾患のバイオマーカー
US11808772B2 (en) * 2017-07-19 2023-11-07 Bio-Rad Europe Gmbh Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
IT201800006129A1 (it) * 2018-06-08 2019-12-08 Uso dello SNP rs17618244 come marcatore predittivo nella NAFLD.
WO2020044497A1 (ja) * 2018-08-30 2020-03-05 国立大学法人 東京大学 Nafld又はnashの検出又はリスクの予測方法、nafld又はnashを検出するための診断薬キット、対象における肝線維化の進行度の判定方法、及び対象における肝線維化の進行度を判定するための診断薬キット

Similar Documents

Publication Publication Date Title
Johnson et al. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
TW209248B (https=)
CN109765378B (zh) 一种新的肝硬化或肝纤维化标志物
Tsutsumi et al. Detection of a unique γ-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma
CN101836112A (zh) 用于在人急性白血病中诱导epha7和erk磷酸化的脱调节的方法和组合物
US20220229060A1 (en) Gender-specific markers for diagnosing prognosis and determining treatment strategy for renal cancer patients
US20250297317A1 (en) Compositions and methods for detection of liver cancer
JP2003508022A5 (https=)
WO2022034300A1 (en) Multiomic analysis of nanoparticle-coronas
JP2008528024A (ja) 肺癌診断用マーカー遺伝子
EP2983693A1 (en) Sept4/ARTS AS A TUMOR SUPPRESSOR IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF HEPATIC DISORDERS
ES2260059T3 (es) Rna mensajero del pca3 en tejidos benignos y malignos de prostata.
JPWO2022064198A5 (https=)
CN106460047B (zh) 用于鉴定癌前结肠直肠息肉和结肠直肠癌的方法及试剂盒
WO2011146937A1 (en) Methods and kits useful in diagnosing nsclc
KR102238258B1 (ko) 간암 진단을 위한 신규 바이오마커 및 이를 이용한 치료 방법
KR102061891B1 (ko) 폐암 질환의 진단용 마커
CN118389661B (zh) Ald肝损伤的非侵入性生物标志物及应用
CN109161595A (zh) 一种用于肝癌诊断的circRNA标志物
CN105154533A (zh) 诊断早期肝癌的miRNA组合及其试剂盒
JP2007511474A5 (https=)
US20100172833A1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
JP7610265B2 (ja) 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法
TW200804811A (en) Methods of diagnosing liver diseases and of screening molecules for the treatment of said diseases
JP2002526760A (ja) 消化器癌を診断、監視、病期分類、イメージング及び治療する新規な方法